Literature DB >> 6224521

Natural killer and suppressor T-cell chronic lymphocytic leukemia.

M Palutke, L Eisenberg, J Kaplan, M Hussain, K Kithier, P Tabaczka, I Mirchandani, D Tenenbaum.   

Abstract

A patient with low-grade lymphocytosis, splenomegaly, and neutropenia, but adequate myeloid leukogenesis, was found to have chronic lymphocytic leukemia, which represented a clonal proliferation of a distinct T-lymphocyte subset. The lymphocytes did not form E rosettes but had an OKT3+, OKT4+, OKT6+, OKT8+, OKT11+, HNK-1+, HNK-36+, OKIa1+, OKM1+ phenotype and functionally had suppressor and natural killer activity. Morphologically, they were large granular lymphocytes, which were strongly acid phosphatase positive and nonspecific esterase negative. They did not respond to mitogens, or to allogeneic cells. Initially, the spleen appeared to be the most involved organ and, judging from the high proportion of leukemic splenic lymphocytes in the S and G2/M phases of the cell cycle, was also the organ of origin of the leukemic cells. Only a few leukemic cells in the blood and bone marrow were in S and G2/M phases. After splenectomy, the lymphocyte count rose considerably and the bone marrow became progressively more infiltrated by tumor nodules. One year after diagnosis, the patient was started on chemotherapy because of progressive anemia. He responded to the chemotherapy by normalization of the hemoglobin and neutrophil count and had a moderate decrease in the bone marrow involvement and peripheral lymphocytosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224521

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  Abnormal expansions of granular lymphocytes: reactive lymphocytosis or chronic leukemia? Case report and literature review.

Authors:  G Gastl; H Rumpold; D Kraft; C Gattringer; G Schuler; R Margreiter; F Schmalzl; C Huber
Journal:  Blut       Date:  1986-02

2.  S-100+ lymph node neoplasm. Report of a case with histological AL and immunological features intermediate between T cell lymphoma and malignant histiocytosis.

Authors:  L P Ruco; A Stoppacciaro; P Barsotti; D Vitolo; M Mirolo; A M Cassano; C Guglielmi; F Mandelli; S Uccini; C D Baroni
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

3.  A lymphoproliferative disorder of granular lymphocytes with a novel phenotype and suppressor function.

Authors:  A Landay; M C Poon; L T Clement; C E Grossi
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

4.  T gamma lymphocytosis is clinically non-progressive but immunologically heterogeneous.

Authors:  F Miedema; F G Terpstra; J W Smit; J P van der Veen; C J Melief
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

5.  Natural killer (NK) cell immunodeficiency in patients with chronic myelogenous leukemia. II. Successful cloning and amplification of natural killer cells.

Authors:  Y Fujimiya; W C Chang; A Bakke; D Horwitz; P K Pattengale
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

6.  Phenotypical and functional heterogeneity of the large granular lymphocytes increased after various treatments in a patient with combined immunodeficiency.

Authors:  S Takagi; J Minakuchi; H Okawa; J Yata
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.